Δ-Catenin Peptide Vaccines Repress Hepatocellular Carcinoma Growth via CD8+ T Cell Activation

OncoImmunology - United States
doi 10.1080/2162402x.2018.1450713
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

IL-33 Released in the Liver Inhibits Tumor Growth via Promotion of CD4+ and CD8+ T Cell Responses in Hepatocellular Carcinoma

Journal of Immunology
AllergyImmunology
2018English

IL-27 and the Generation of CD8+T-cell Responses to Peptide Vaccines: Fig. 1.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2014English

Overexpression of P62/Imp2 Can Promote Cell Migration in Hepatocellular Carcinoma via Activation of the WNT/Β-Catenin Pathway

Cancers
Cancer ResearchOncology
2019English

Inefficient Induction of Circulating TAA-specific CD8+ T-Cell Responses in Hepatocellular Carcinoma

Oncotarget
Oncology
2019English

Tuning Antiviral CD8 T-Cell Response via Proline-Altered Peptide Ligand Vaccination

2019English

CD8+ Memory T-Cell Inflation Renders Compromised CD4+ T-Cell-Dependent CD8+ T-Cell Immunity via Naïve T-Cell Anergy

ImmunoTargets and Therapy
AllergyImmunology
2017English

Amphiregulin Activates Regulatory T Lymphocytes and Suppresses CD8+ T Cell-Mediated Anti-Tumor Response in Hepatocellular Carcinoma Cells

Oncotarget
Oncology
2015English

Δ‐Catenin Regulates Proliferation and Apoptosis in Renal Cell Carcinoma via Promoting Β‐catenin Nuclear Localization and Activating Its Downstream Target Genes

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2020English

NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines

Cell
BiochemistryGeneticsMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy